These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8193093)

  • 1. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.
    Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Tuohy P; O'Callaghan C; Mitchell JR; Symonds EM
    Br J Obstet Gynaecol; 1994 Mar; 101(3):203-8. PubMed ID: 8193093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.
    Louden KA; Broughton Pipkin F; Symonds EM; Tuohy P; O'Callaghan C; Heptinstall S; Fox S; Mitchell JR
    Br J Obstet Gynaecol; 1992 May; 99(5):371-6. PubMed ID: 1622907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose aspirin in pregnancy.
    Sibai BM; Mirro R; Chesney CM; Leffler C
    Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia.
    Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Mitchell JR; Symonds EM
    Br J Obstet Gynaecol; 1991 Dec; 98(12):1239-44. PubMed ID: 1777456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn.
    Viinikka L; Hartikainen-Sorri AL; Lumme R; Hiilesmaa V; Ylikorkala O
    Br J Obstet Gynaecol; 1993 Sep; 100(9):809-15. PubMed ID: 8217999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
    Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin.
    Finneran MM; Gonzalez-Brown VM; Smith DD; Landon MB; Rood KM
    Am J Obstet Gynecol; 2019 Apr; 220(4):385.e1-385.e6. PubMed ID: 30786253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
    Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
    Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
    Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
    Regan CL; McAdam BF; McParland P; Boylan PC; FitzGerald GA; Fitzgerald DJ
    Br J Obstet Gynaecol; 1998 Jul; 105(7):732-8. PubMed ID: 9692413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin and platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation.
    Kilby MD
    Br J Obstet Gynaecol; 1994 Nov; 101(11):1023. PubMed ID: 7864999
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
    Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
    Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitor, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin.
    Hoet B; Falcon C; De Reys S; Arnout J; Deckmyn H; Vermylen J
    Blood; 1990 Feb; 75(3):646-53. PubMed ID: 2153424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.
    Hauth JC; Goldenberg RL; Parker CR; Copper RL; Cutter GR
    Am J Obstet Gynecol; 1995 Aug; 173(2):578-84. PubMed ID: 7645637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.
    Wallenburg HC; Dekker GA; Makovitz JW; Rotmans P
    Lancet; 1986 Jan; 1(8471):1-3. PubMed ID: 2867260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N; Atkinson PM; Bradlow BA
    S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.